These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 12084397)
1. Protective effects of estrogen on the cardiovascular system. Mendelsohn ME Am J Cardiol; 2002 Jun; 89(12A):12E-17E; discussion 17E-18E. PubMed ID: 12084397 [TBL] [Abstract][Full Text] [Related]
2. Drug targeting of estrogen receptor signaling in the cardiovascular system: preclinical and clinical studies. Sanz-González SM; Cano A; Valverde MA; Hermenegildo C; Andrés V Curr Med Chem Cardiovasc Hematol Agents; 2004 Apr; 2(2):107-22. PubMed ID: 15320794 [TBL] [Abstract][Full Text] [Related]
3. Genomic and nongenomic effects of estrogen in the vasculature. Mendelsohn ME Am J Cardiol; 2002 Jul; 90(1A):3F-6F. PubMed ID: 12106632 [TBL] [Abstract][Full Text] [Related]
4. Vasomotor and vascular effects of hormone replacement therapy. Ganz P Am J Cardiol; 2002 Jul; 90(1A):11F-16F. PubMed ID: 12106634 [TBL] [Abstract][Full Text] [Related]
5. Estrogen actions in the cardiovascular system. Mendelsohn ME Climacteric; 2009; 12 Suppl 1():18-21. PubMed ID: 19811235 [TBL] [Abstract][Full Text] [Related]
6. Oestrogen and the cardiovascular system: the good, the bad and the puzzling. Gray GA; Sharif I; Webb DJ; Seckl JR Trends Pharmacol Sci; 2001 Mar; 22(3):152-6. PubMed ID: 11239579 [TBL] [Abstract][Full Text] [Related]
9. Animal models of the cardiovascular effects of exogenous hormones. Karas RH Am J Cardiol; 2002 Jul; 90(1A):22F-25F. PubMed ID: 12106636 [TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. Chen Z; Yuhanna IS; Galcheva-Gargova Z; Karas RH; Mendelsohn ME; Shaul PW J Clin Invest; 1999 Feb; 103(3):401-6. PubMed ID: 9927501 [TBL] [Abstract][Full Text] [Related]
11. Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean? Mendelsohn ME Circ Res; 2000 Nov; 87(11):956-60. PubMed ID: 11090536 [TBL] [Abstract][Full Text] [Related]
12. [The effects of estrogen in the cardiovascular system]. Finking G; Gohar MH; Lenz C; Hanke H Z Kardiol; 2000 May; 89(5):442-53. PubMed ID: 10900675 [TBL] [Abstract][Full Text] [Related]
14. Estrogens and atherosclerosis: phytoestrogens and selective estrogen receptor modulators. St Clair RW Curr Opin Lipidol; 1998 Oct; 9(5):457-63. PubMed ID: 9812200 [TBL] [Abstract][Full Text] [Related]
15. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Simoncini T; Genazzani AR; Liao JK Circulation; 2002 Mar; 105(11):1368-73. PubMed ID: 11901050 [TBL] [Abstract][Full Text] [Related]
16. Estrogen and cardiovascular disease. Lobo RA Ann N Y Acad Sci; 1990; 592():286-94; discussion 334-45. PubMed ID: 2197947 [No Abstract] [Full Text] [Related]
17. Vascular effects of estrogens: rapid actions, novel mechanisms, and potential therapeutic implications. Barton M Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):682-90. PubMed ID: 10678098 [TBL] [Abstract][Full Text] [Related]
18. Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation. Barton M; Meyer MR; Prossnitz ER J Cardiovasc Pharmacol; 2013 Jul; 62(1):22-5. PubMed ID: 23615160 [TBL] [Abstract][Full Text] [Related]
19. Rapid estrogen actions in the cardiovascular system. Simoncini T; Mannella P; Genazzani AR Ann N Y Acad Sci; 2006 Nov; 1089():424-30. PubMed ID: 17261785 [TBL] [Abstract][Full Text] [Related]